Fisetin Market Report 2026

The fisetin market size has grown rapidly in recent years. It will grow from $3.8 billion in 2025 to $4.31 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increasing consumption of dietary supplements, growth of antioxidant research, availability of plant-derived flavonoids, expansion of supplement manufacturing capacity, rising consumer interest in preventive health.

The fisetin market size is expected to see rapid growth in the next few years. It will grow to $7.09 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing investments in longevity research, growing demand for premium nutraceuticals, expansion of pharmaceutical applications, rising use in cosmetic formulations, increasing focus on bioavailability enhancement. Major trends in the forecast period include increasing demand for flavonoid-based supplements, rising use of natural antioxidants, expansion of anti-aging product applications, increasing focus on high-purity compounds, enhanced research and clinical validation.

The increasing emphasis on wellness and health is expected to drive the growth of the fisetin market in the coming years. Wellness focuses on achieving overall well-being through practices that support physical, mental, and emotional health, while health refers to the state of being free from illness or injury, supported by lifestyle choices and medical care. The growing attention to wellness and health is influenced by advancements in healthcare and a broader cultural focus on personal well-being and quality of life. Fisetin offers a range of potential benefits that make it an attractive compound for general health and wellness applications. Its inclusion in functional beverages and supplements adds value by offering possible health benefits, including support for insulin sensitivity and glucose metabolism. For example, in November 2024, according to the Global Wellness Institute, a US-based international nonprofit organization dedicated to wellness research, the global wellness economy expanded from approximately $5.8 trillion in 2022 to about $6.3 trillion in 2023, reflecting nearly 9% year-on-year growth. Therefore, the increasing focus on wellness and health is supporting the growth of the fisetin market.

Companies in the fisetin market are increasingly concentrating on innovation through human clinical trials to improve the bioavailability and effectiveness of fisetin in dietary supplements and functional food products. Human clinical trials are essential scientific studies conducted with volunteers to assess the safety, efficacy, and potential health benefits of compounds, enabling the transition from preclinical research to broader human use. For instance, in August 2024, Bonerge Lifescience, a China-based provider of health-focused ingredients, announced the initiation of clinical trials for its branded ingredients GlucoSober and BeFisetin. GlucoSober is a proprietary ingredient developed to support healthy blood sugar levels, while BeFisetin is a branded fisetin extract with purity levels ranging from 50% to 99%, including the first fisetin extract to reach 99% purity. The company emphasizes sustainable and environmentally responsible sourcing of raw materials, with product safety as a core priority.

In November 2023, Bioriginal Food and Science Corporation, a Canada-based provider of nutritional solutions, acquired Softgel Co. for an undisclosed amount. This acquisition was aimed at expanding Bioriginal’s dietary supplement portfolio and strengthening its capabilities in supplement formulation by utilizing Softgel Co.’s expertise in softgel manufacturing. Softgel Co. is a US-based company specializing in softgel production and supplies fisetin for softgel applications.

Major companies operating in the fisetin market are Sigma-Aldrich Co. LLC, Bio-Techne Corporation, Toronto Research Chemicals Inc., Cayman Chemical Company, Cayman Chemical Company, Selleck Chemicals LLC, Santa Cruz Biotechnology Inc., Stanford Chemicals Company, Conscientia Industrial Co. Ltd., AIDP Inc., Simagchem Corporation, Xi’an SR Bio-Engineering Co. Ltd., AdooQ BioScience LLC, Wilshire Technologies LLC, Meite Chemical Co. Ltd., Chengdu Biopurify Phytochemicals Ltd., Indofine Chemical Company Inc., Otto Chemie Pvt. Ltd., Hebei Lingding Biotechnology Co. Ltd.

North America was the largest region in the fisetin market in 2025. The regions covered in the fisetin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the fisetin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The fisetin market consists of sales of fisetin glycosides, supplemental forms of fisetin, and fisetin for research purposes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.